Navigation Links
GlobalCare Clinical Trials, Ltd Announces Company Expansion Into Latin America
Date:3/9/2011

ience

With more than 100 years of collective experience in the clinical trials and home healthcare industries, the GlobalCare team has supported more than 350 trials, including several studies leading to commercialization of blockbuster products. With three decades of comprehensive phase I-IV clinical trials leadership, CEO Adinamis is also the founder and pioneer of the in-home and alternate site clinical trials model, which she introduced in 1992. Adinamis also spent 12 years in global clinical trials management at Abbott Laboratories and Astellas Pharma and established and led clinical trials divisions for three national home infusion companies as well as her former company, Clinical Resource Network, Inc.

Adinamis is joined by Janusz Kabata, MD, PhD, MBA, who serves as Chief Medical Officer and Director of European Operations for GlobalCare. Kabata brings over 30 years of medical experience to the company as an academic researcher and Medical Director in private healthcare institutions. He also provided two decades of work in successful coordination and management of international clinical trials.  

About GlobalCare Clinical Trials, Ltd

GlobalCare Clinical Trials, Ltd is a global niche service provider to government agencies and the world's biotechnology, pharmaceutical and medical device companies engaged in all phases of product development. GlobalCare offers an innovative patient-centric service model that provides selected clinical study visits in the home or alternate setting resulting in faster patient recruitment, better compliance and higher retention rates, helping to expedite time-to-market for life-enhancing products. Services are provided in over 20 countries, through an extensive network of multilingual Country Coordinators and over 20,000 local highly skilled ambulant clinicians in compliance with local and national regulations. Services include Global Project Management, local and central pharmacy servic
'/>"/>

SOURCE GlobalCare Clinical Trials, Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
2. ARCA biopharma Appoints William R. Hiatt as Director of Clinical and Regulatory Strategy
3. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
4. Association of Clinical Research Organizations (ACRO) Welcomes Clinilabs and RPS as New Members
5. NovaRx Initiates Pivotal Phase III Clinical Trial in Lung Cancer Patients
6. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
7. Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
8. /R E P E A T -- Oncolytics Biotech Inc. Announces U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours/
9. CV Therapeutics Initiates Phase 1 Clinical Trial of CVT-3619, a Novel Potential Treatment for Cardiometabolic Diseases
10. Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontologys 94th Annual Meeting
11. ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Chester, OH (PRWEB) November 25, 2014 ... Holdings, has joined the Graphel Carbon Products team as ... in sales, marketing, and customer service for the graphite ... add Miles to our team,” stated Dave Trinkley, VP ... “His wide range of experience in the graphite ...
(Date:11/26/2014)... , 25 novembre 2014 Theravalues Corporation ... sur le marché européen au salon Hi Europe ... Amsterdam ). Curcumine la plus ... technologie amorphe (non-cristalline) à des ingrédients approuvés par ... un pigment jaune présent dans la racine de ...
(Date:11/24/2014)... BUENA, N.J. , Nov. 24, 2014  IGI ... Jersey based specialty generic pharmaceutical company, today ... application (ANDA) to the U.S. Food and Drug Administration ... submissions in 2014 to seven, with eighteen submissions now ... Grenfell-Gardner , President and CEO of the Company, commented, ...
(Date:11/24/2014)... November 24, 2014   ... ScienceDirect   Elsevier , a world-leading provider ... pleased to announce the launch of the latest title in ... Current Opinion in Food Science . ... specialists with a new platform to keep up-to-date with the ...
Breaking Biology Technology:Miles Holder Joins Graphel Corporation as Sales/Marketing Manager 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 2La curcumine présentant la plus haute biodisponibilité bientôt en vente en Europe 3IGI Laboratories, Inc. Announces ANDA Submission 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... Brings Both Clinical Trial Experience and Business ... Role, CAMBRIDGE, Mass., Jan. 16 Cytel, ... executive Irving Dark has,accepted the role of Vice ... to Cytel 15-years of management experience guiding drug,biologic ...
... BASEL, Switzerland, Jan. 16 Roche (OTCQX:,RHHBY; SWX: ROG.VX; ... today that it has extended its,offer to acquire all ... (Nasdaq: VMSI ) to 5:00 p.m., New York ... was previously scheduled to expire at 5:00,p.m., New York ...
... NEW YORK, Jan. 16 With the field ... research, the Society for Biological Engineering,(SBE) has organized ... conference, which runs from January 20th to 23rd ... will focus on,engineering designs for stem cell production, ...
Cached Biology Technology:Irving Dark Named Vice President of Cytel Clinical Research Services 2Roche Extends Tender Offer for Ventana 2Roche Extends Tender Offer for Ventana 3Roche Extends Tender Offer for Ventana 4Roche Extends Tender Offer for Ventana 5Society for Biological Engineering Holds First International Conference on Stem Cell Engineering 2
(Date:11/4/2014)... 4, 2014   Neurotechnology , a provider ... the latest version of its fingerprint matching algorithm ... MINEX evaluation organized by NIST. The MINEX ... the INCITS 378 fingerprint standard template format. MINEX ... tenders in the United States ...
(Date:11/3/2014)... study published in this month,s Proceedings of ... of a recently discovered communication molecule of the body,s ... known to limit inflammation and the current study reports ... the ability of the immune system to recognize and ... IL-37,s effect on the immune system now allows us ...
(Date:11/3/2014)... weight and preterm birth are linked to increased risk ... in the American College of Rheumatology (ACR) journal, ... weight and pre-term babies were not at greater risk ... , According to the ACR, 27 million Americans over ... Symptoms of OA range from mild to severe and ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2
... who have adapted a three-dimensional, general circulation model of ... ago when the sun was significantly fainter than present ... catastrophic glaciation than previously believed. The new 3-D ... from about 3.8 billion years to 2.5 billion years ...
... Managing commercial and recreational fisheries is a complex ... and regulatory agencies don,t always see eye-to-eye. Researchers ... now working with commercial fishermen to collect and share ... build trust and foster the mutual goal of sustainable ...
... neurodegenerative diseases such as Parkinson,s and Alzheimer,s, cancer and ... partially caused or accelerated by oxidative stress. Oxidative stress ... what are called reactive oxygen species (ROS). "However, up ... changes in a living organism and certainly not how ...
Cached Biology News:Early Earth may have been prone to deep freezes, says CU-Boulder study 2Early Earth may have been prone to deep freezes, says CU-Boulder study 3Public-private partnership helps monitor fish populations 2Public-private partnership helps monitor fish populations 3Public-private partnership helps monitor fish populations 4Public-private partnership helps monitor fish populations 5Oxidative stress: Less harmful than suspected? 2
... Panels were designed for full-length gene cloning ... to identify the desired cDNA clone. The ... 96-well "Master Plate," where each well contains ... the positive well(s) by gel electrophoresis of ...
... Preparation Note: Prepared by a ... C.W., et al., Biotechnol. Bioeng., ... Definition: One unit will yield an ... 1.0 ml of water (1 cm ...
... Dithiothreitol DTT White solid.. ... disulfides to thiols, so reaction is "driven" to ... not contain waxy surfactant found in many other ... pentobarbitol. Purity: ≥97% by titration. ...
... Basically, most ``special`` dye stains are ... few other non-routine) stains are $9.00. ... a paraffin block, staining, coverslipping and ... (for senile plaques) ,Bodian`s Stain ,Copper ...
Biology Products: